| Pfizer AG - Vydura 75 mg, Lyophilisat zum Einnehmen |
| 69035 | | 01 | | Vydura 75 mg | | Lyophilisat zum Einnehmen | | N02CD06 | | Rimegepant | | 18.10.2023 | | |
|
| Composition |
| rimegepantum 75 mg ut rimegepanti hemisulfas sesquihydricus, gelatina, mannitolum, sucralosum, aromatica (Minze) cum alcohol benzylicus, pro compresso. |
| Packungsbestandteile |
| Soluble Powder | | | | | Active Agent | Dose |
|---|
| Rimegepantum | 75 mg |
| | BAG: Active Agent | Dose |
|---|
| Rimegepantum | 75 mg |
| | | | Inactive agents |
|---|
| Aromatica (Minze) cum Alcohol Benzylicus | | Gelatina | | Mannitol | | Pro Compresso | | Sucralosum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 2 | 50.61 | 74.55 | B | SL | No | | 002 | 8 | 202.53 | 249.15 | B | SL | No | | 003 | 16 | 404.89 | 481.70 | B | SL | No |
|
